120 results
Page 3 of 6
8-K
EX-99.1
14y 5tts34
10 Jun 22
InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector
4:36pm
8-K
EX-10.2
81ue8up
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.1
9nsrh97dbh0
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.3
wk2fh1x311
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.3
pvuj8tbahtp51 vgispv
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.2
gx0p7pldpt8vyl6
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
y2jx1zpg
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
h8ee88v2q5rj
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
djet67yrcx38
25 Apr 22
Prospectus supplement
5:02pm
424B3
6fdb2lr rqgsq7p
7 Apr 22
Prospectus supplement
4:46pm
8-K
EX-10.1
xhrdf
22 Mar 22
Entry into a Material Definitive Agreement
6:05am
S-3
pqr h3egu
4 Feb 22
Shelf registration
4:36pm
8-K/A
EX-99.1
9dc3sq39gxs
22 Dec 21
Audited Financial Statements
12:00am
DEF 14A
esrdns yw
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-2.1
scp80f3yip
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
3e65cchsqgregx5s
24 Sep 21
Annual report
7:31am
10-K
EX-2.1
u6e836sc 91ky4l7
24 Sep 21
Annual report
7:31am